Want to join the conversation?
$ZTS 2Q15 Call: On track to deliver at least $300MM of OpEx reduction by 2017. One-time costs broken down as, one which is associated with Pfizer of $39MM; recorded $263MM of costs associated with operational efficiency initiative; bucket for supply network strategy which had $15MM of charges.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?